orlistat has been researched along with Leukemia--T-Cell* in 1 studies
1 other study(ies) available for orlistat and Leukemia--T-Cell
Article | Year |
---|---|
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line.
Fatty Acid Synthase (FASN) is responsible for the Topics: B7-H1 Antigen; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Humans; Jurkat Cells; Leukemia, T-Cell; Orlistat | 2020 |